Williams Lamario J, Nye Brenna G, Wende Adam R
Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Endocrinol Metab (Seoul). 2017 Jun;32(2):171-179. doi: 10.3803/EnM.2017.32.2.171.
The proposal that diabetes plays a role in the development of heart failure is supported by the increased risk associated with this disease, even after correcting for all other known risk factors. However, the precise mechanisms contributing to the condition referred to as diabetic cardiomyopathy have remained elusive, as does defining the disease itself. Decades of study have defined numerous potential factors that each contribute to disease susceptibility, progression, and severity. Many recent detailed reviews have been published on mechanisms involving insulin resistance, dysregulation of microRNAs, and increased reactive oxygen species, as well as causes including both modifiable and non-modifiable risk factors. As such, the focus of the current review is to highlight aspects of each of these topics and to provide specific examples of recent advances in each area.
糖尿病在心力衰竭发展中起作用这一观点得到了支持,即使校正了所有其他已知风险因素,与该疾病相关的风险仍会增加。然而,导致所谓糖尿病性心肌病的精确机制仍然难以捉摸,对该疾病本身的定义也是如此。数十年的研究已经确定了许多潜在因素,每个因素都对疾病易感性、进展和严重程度有影响。最近发表了许多详细综述,涉及胰岛素抵抗、微小RNA失调、活性氧增加等机制,以及包括可改变和不可改变风险因素在内的病因。因此,本综述的重点是突出这些主题各自的方面,并提供每个领域近期进展的具体例子。